A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II
1997

Surgery and Chemotherapy for Gastric Lymphoma

Sample size: 25 publication Evidence: moderate

Author Information

Author(s): T Takenaka, K Maruyama, T Kinoshita, M Sasako, T Sano, H Katai, Y Matsuno

Primary Institution: National Cancer Center Hospital, Tokyo, Japan

Hypothesis

Can combined surgery and chemotherapy effectively treat primary gastric lymphoma stage II?

Conclusion

Primary gastric lymphoma stage II can be effectively treated with surgery followed by adjuvant chemotherapy.

Supporting Evidence

  • Twenty-one of the 25 patients who completed post-operative chemotherapy were free of relapse for a median of 94 months.
  • The overall survival rate for the patients was 81.6% at 10 years.
  • The disease-free survival rate was 92.0% at 10 years.

Takeaway

Doctors can help people with a type of stomach cancer by doing surgery and giving them medicine afterward to keep them healthy.

Methodology

Patients underwent surgery followed by a specific chemotherapy regimen, and their outcomes were tracked over time.

Limitations

The study was limited to a small sample size and a specific stage of gastric lymphoma.

Participant Demographics

The study included 25 patients, with 14 women and 11 men, aged 36 to 82 years.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication